Cameron R. Wolfe

7.5k citations
97 papers · 2.4k indexed · 3 hit papers · h-index 21

Impact in

Papers in

Cameron R. Wolfe

89 papers receiving 2.3k citations

Hit Papers

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus 2021 · 230 citations
2302018202620202023100200300400

Peers

Cameron R. Wolfe
Comparison fields: 5 of 129
  • Transplantation 220
  • Infectious Diseases 1.1k
  • Epidemiology 1.4k
  • Applied Microbiology and Biotechnology 45
  • Hepatology 118
Replace Sherif B. Mossad with:
Sherif B. Mossad United States
Daniel Kaul United States
Matthew P. Cheng Canada
Gopi Patel United States
Katia Boggian Switzerland
Elisa Cordero Spain
Jeffrey Topal United States
Anita Verma United Kingdom
Daniel Vittecoq France
Fainareti N. Zervou United States
Cameron R. Wolfe relative to Sherif B. Mossad United States Sherif B. Mossad's profile →
Citations per field
00.5×4.1×
Sherif B. Mossad · 1×
Citations per year

Countries citing papers authored by Cameron R. Wolfe

Since Specialization
Citations

This map shows the geographic impact of Cameron R. Wolfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cameron R. Wolfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cameron R. Wolfe more than expected).

Fields of papers citing papers by Cameron R. Wolfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cameron R. Wolfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cameron R. Wolfe. The network helps show where Cameron R. Wolfe may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Cameron R. Wolfe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cameron R. Wolfe Line = papers co-authored together Cameron R. Wolfe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20250
4 20251
5 20243
6 20243
7 20241
8 20246
9 20242
10 20242
11 20235
12 20239
13 20234
14 20237
15 20232
16 202124
17
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus
Hit paper breakdown →
2021230
18 20199
19 20184
20 201040

About Cameron R. Wolfe

Cameron R. Wolfe is a scholar working on Transplantation, Infectious Diseases, Hepatology, Epidemiology and Virology, having authored 97 papers that have together received 2.4k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (21 papers), Cytomegalovirus and herpesvirus research (15 papers), Transplantation: Methods and Outcomes (13 papers), Respiratory viral infections research (12 papers), Hepatitis C virus research (12 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Mycobacterium research and diagnosis (10 papers) and Influenza Virus Research Studies (8 papers). The work is most often cited by research in Transplantation (220 citations), Infectious Diseases (1.1k citations), Epidemiology (1.4k citations), Applied Microbiology and Biotechnology (45 citations) and Hepatology (118 citations). Cameron R. Wolfe has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Michael G. Ison, Alicia M. Fry, Shandra L. Knight, Frederick G. Hayden, Paul Alexander, Scott A. Harper, Henry H. Bernstein, Laura E. Riley, Bree Johnston and Stefan Gravenstein. Their work appears in journals such as The Journal of Heart and Lung Transplantation, American Journal of Transplantation, Open Forum Infectious Diseases, Clinical Infectious Diseases and Clinical Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026